Cargando…
Dynamically prognosticating patients with hepatocellular carcinoma through survival paths mapping based on time-series data
Patients with hepatocellular carcinoma (HCC) always require routine surveillance and repeated treatment, which leads to accumulation of huge amount of clinical data. A predictive model utilizes the time-series data to facilitate dynamic prognosis prediction and treatment planning is warranted. Here...
Autores principales: | Shen, Lujun, Zeng, Qi, Guo, Pi, Huang, Jingjun, Li, Chaofeng, Pan, Tao, Chang, Boyang, Wu, Nan, Yang, Lewei, Chen, Qifeng, Huang, Tao, Li, Wang, Wu, Peihong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5993743/ https://www.ncbi.nlm.nih.gov/pubmed/29884785 http://dx.doi.org/10.1038/s41467-018-04633-7 |
Ejemplares similares
-
High number of PD‐1 positive intratumoural lymphocytes predicts survival benefit of cytokine‐induced killer cells for hepatocellular carcinoma patients
por: Chang, Boyang, et al.
Publicado: (2018) -
The correlation and prognostic value of serum levels of soluble programmed death protein 1 (sPD-1) and soluble programmed death-ligand 1 (sPD-L1) in patients with hepatocellular carcinoma
por: Chang, Boyang, et al.
Publicado: (2018) -
Identification and Validation of a Prognostic lncRNA Signature for Hepatocellular Carcinoma
por: Li, Wang, et al.
Publicado: (2020) -
Alternative splicing events are prognostic in hepatocellular carcinoma
por: Chen, Qi-Feng, et al.
Publicado: (2019) -
Bioinformatic analysis and in vitro validation of a five-microRNA signature as a prognostic biomarker of hepatocellular carcinoma
por: Li, Wang, et al.
Publicado: (2020)